Advertisement

Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

  • A. AbbasiEmail author
  • E. Corpeleijn
  • E. Meijer
  • D. Postmus
  • R. T. Gansevoort
  • R. O. B. Gans
  • J. Struck
  • H. L. Hillege
  • R. P. Stolk
  • G. Navis
  • S. J. L. Bakker
Correction
  • 46 Downloads

Correction to: Diabetologia

  https://doi.org/10.1007/s00125-012-2545-x

The values given for copeptin levels in men in quartiles 1 and 2 (Table 1) were incorrect, and should have read:

Quartile 1: 3.0 (2.3–3.5)

Quartile 2: 5.1 (4.6–5.6)

The total hs-CRP value in men should have read 1.20 (0.55–2.64).

The corrected table is reproduced here.
Table 1

Baseline clinical characteristics of participants in total and according to quartiles of plasma copeptin

Characteristic

Total

Sex-specific quartiles

p valuea

1

2

3

4

Women

 No. of participants

4063

1001

1025

1019

1018

 Copeptin level (pg/ml)

3.6 (2.4–5.5)

1.8 (1.4–2.1)

2.9 (2.6–3.2)

4.4 (4.0–4.9)

7.6 (6.3–9.8)

 Age (years)

47.7 ± 12.2

46.7 ± 12.2

46.8 ± 11.8

47.8 ± 12.2

49.6 ± 12.3

<0.001

 Family history of diabetes (%)

830 (20.4)

202 (20.2)

190 (18.5)

208 (20.4)

230 (22.6)

0.16

 Current smoker (%)

1374 (33.8)

275 (27.5)

313 (30.5)

366 (35.9)

420 (41.3)

<0.001

 Ever use alcohol (%)

2718 (67.2)

641 (64.2)

707 (69.2)

684 (67.5)

686 (67.9)

0.10

 BMI (kg/m2)

25.8 ± 4.6

25.4 ± 4.1

25.6 ± 4.5

26.0 ± 4.7

26.2 ± 5.2

<0.001

 Waist circumference (cm)

82.9 ± 12.4

81.2 ± 11.1

82.5 ± 12.3

83.4 ± 12.3

84.3 ± 13.6

<0.001

 Systolic blood pressure (mmHg)

119.4 ± 19.5

118.3 ± 18.7

118.4 ± 18.6

119.7 ± 19.8

121.1 ± 20.9

0.003

 Diastolic blood pressure (mmHg)

68.7 ± 9.0

68.3 ± 8.9

68.5 ± 8.8

68.7 ± 9.2

69.4 ± 9.0

0.03

 Hypertension (%)

959 (23.6)

222 (22.2)

216 (21.1)

235 (23.1)

286 (28.1)

0.001

 Glucose (mmol/l)

4.62 ± 0.64

4.61 ± 0.60

4.59 ± 0.59

4.61 ± 0.62

4.67 ± 0.71

0.04

 Total cholesterol (mmol/l)

5.60 ± 1.14

5.56 ± 1.15

5.51 ± 1.12

5.61 ± 1.15

5.71 ± 1.15

0.001

 HDL-cholesterol (mmol/l)

1.49 ± 0.41

1.49 ± 0.41

1.49 ± 0.40

1.47 ± 0.39

1.50 ± 0.41

0.44

 Triacylglycerol (mmol/l)

1.05 (0.78–1.46)

1.02 (0.76–1.43)

1.04 (0.77–1.45)

1.06 (0.78–1.48)

1.06 (0.80–1.50)

0.13

 hs-CRP (mg/l)

1.31 (0.55–3.21)

1.20 (0.50–3.19)

1.26 (0.53–3.01)

1.35 (0.61–3.27)

1.46 (0.58–3.34)

0.03

 UAE (mg/24 h)

10.4 (6.8–20.6)

7.3 (5.5–11.7)

8.2 (5.7–13.1)

8.3 (5.8–13.7)

9.8 (6.3–17.7)

<0.001

Men

 No. of participants

3909

973

980

978

978

 Copeptin level (pg/ml)

6.2 (4.0–9.4)

3.0 (2.3–3.5)

5.1 (4.6–5.6)

7.6 (6.9–8.5)

12.5 (10.5–15.5)

 Age (years)

50.2 ± 1.8

49.3 ± 12.6

49.5 ± 12.9

49.9 ± 12.6

52.2 ± 12.8

<0.001

 Family history of diabetes (%)

753 (19.3)

187 (19.2)

169 (17.2)

206 (21.1)

191 (19.5)

0.20

 Current smoker (%)

1369 (35.0)

319 (32.8)

347 (35.4)

361 (36.9)

342 (35.0)

0.29

 Ever use alcohol (%)

3210 (82.5)

794 (81.8)

821 (84.3)

798 (81.9)

797 (81.9)

0.40

 BMI (kg/m2)

26.2 ± 3.6

25.8 ± 3.4

26.1 ± 3.5

26.4 ± 3.6

26.5 ± 3.8

<0.001

 Waist circumference (cm)

93.6 ± 10.9

92.6 ± 10.4

92.7 ± 10.9

94.0 ± 10.8

94.9 ± 11.4

<0.001

 Systolic blood pressure (mmHg)

128.7 ± 17.8

126.5 ± 17.3

127.5 ± 17.5

129.9 ± 17.4

131.0 ± 18.8

<0.001

 Diastolic blood pressure (mmHg)

74.7 ± 9.5

73.2 ± 9.1

74.2 ± 9.4

75.2 ± 9.3

76.1 ± 10.0

<0.001

 Hypertension (%)

1278 (32.7)

273 (28.1)

317 (32.3)

316 (32.3)

372 (38.0)

<0.001

 Glucose (mmol/l)

4.86 ± 0.66

4.82 ± 0.66

4.80 ± 0.61

4.86 ± 0.65

4.95 ± 0.70

<0.001

 Total cholesterol (mmol/l)

5.68 ± 1.10

5.60 ± 1.04

5.64 ± 1.10

5.66 ± 1.09

5.81 ± 1.17

<0.001

 HDL-cholesterol (mmol/l)

1.16 ± 0.31

1.17 ± 0.31

1.16 ± 0.30

1.15 ± 0.31

1.17 ± 0.35

0.19

 Triacylglycerol (mmol/l)

1.28 (0.91–1.88)

1.24 (0.89–1.75)

1.23 (0.90–1.80)

1.30 (0.93–1.90)

1.35 (0.95–2.00)

<0.001

 hs-CRP (mg/l)

1.20 (0.55–2.64)

1.03 (0.47–2.28)

1.08 (0.52–2.50)

1.22 (0.58–2.74)

1.45 (0.70–3.11)

<0.001

 UAE (mg/24 h)

8.3 (5.8–13.9)

9.3 (6.4–17.2)

9.7 (6.6–19.3)

10.7 (7.1–20.0)

11.9 (7.4–27.9)

<0.001

Data are given as mean ± SD or median (IQRs) for continuous variables, tested using ANOVA or the Kruskal–Wallis test, and numbers (percentage) for categorical variables, tested using the χ2 test

aUnivariate analyses were for comparison across sex-specific quartiles of plasma copeptin

Notes

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • A. Abbasi
    • 1
    • 2
    Email author
  • E. Corpeleijn
    • 1
  • E. Meijer
    • 2
  • D. Postmus
    • 1
  • R. T. Gansevoort
    • 2
  • R. O. B. Gans
    • 2
  • J. Struck
    • 3
  • H. L. Hillege
    • 1
  • R. P. Stolk
    • 1
  • G. Navis
    • 2
  • S. J. L. Bakker
    • 2
  1. 1.Department of EpidemiologyUniversity of Groningen, University Medical Center GroningenGroningenthe Netherlands
  2. 2.Department of Internal MedicineUniversity of Groningen, University Medical Center GroningenGroningenthe Netherlands
  3. 3.Department of ResearchBRAHMS GmbH/Thermo Fisher ScientificHennigsdorfGermany

Personalised recommendations